Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981433 · ClinicalTrials.gov registry record
Vulvodynia: Identification of Potential Relevant Biomarkers
A clinical trial, sponsored by St. Louis University.
- Completed
- Registry status
- 2
- Enrollment target
NCT02981433 is a clinical trial that has completed, run by St. Louis University. The registered enrollment target is 2 participants.
The verdict
NCT02981433 has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Vulvodynia is a syndrome of unexplained vulvar pain that is frequently accompanied by physical disabilities, limitation of daily activities (such as sitting and walking), sexual dysfunction and psychologic disability. Originally suggested by McKay, the term "vulvodynia" has also been suggested by the International Society for the Study of Vulvar Disease Task Force to describe any vulvar pain. The incidence and prevalence of vulvodynia have not been well studied. Age distribution for the condition may range from the 20s to the 60s, and it is limited almost exclusively to white women. Obstetric and gynecologic history is usually unremarkable. Risk-taking sexual behavior is rare, and few patients have a history of sexually transmitted diseases. Vulvar pain usually has an acute onset, at times associated with episodes of vaginitis or certain therapeutic procedures of the vulva (cryotherapy or laser therapy). In most cases, vulvodynia becomes a chronic problem lasting months to years. Vulvar pain is frequently described as burning or stinging, or a feeling of rawness or irritation. Most patients consult several physicians before being diagnosed. Many are treated with multiple topical or systemic medications, with minimal relief. In some cases, inappropriate therapy may even make the symptoms worse. Since physical findings are few and cultures and biopsies are frequently negative, patients may be told that the problem is primarily psychologic, thus invalidating their pain and adding to their distress.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2020-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02981433
The ClinicalTrials.gov registry entry for NCT02981433 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02981433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02981433 about?
NCT02981433 is a clinical study titled "Vulvodynia: Identification of Potential Relevant Biomarkers". Vulvodynia is a syndrome of unexplained vulvar pain that is frequently accompanied by physical disabilities, limitation of daily activities (such as sitting and walking), sexual dysfunction and psychologic disability. Originally suggested by McKay, the term "vulvodynia" has also been suggested by th...
What is the current status of trial NCT02981433?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2019-03-13. Estimated completion is 2020-06-10.
Who is sponsoring clinical trial NCT02981433?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.